These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25431209)

  • 1. Rate modulation drugs in atrial fibrillation: what is the clinical impact?
    Costea AI; Platonov PG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):142-4. PubMed ID: 25431209
    [No Abstract]   [Full Text] [Related]  

  • 2. Rate-control drugs affect variability and irregularity measures of RR intervals in patients with permanent atrial fibrillation.
    Corino VD; Ulimoen SR; Enger S; Mainardi LT; Tveit A; Platonov PG
    J Cardiovasc Electrophysiol; 2015 Feb; 26(2):137-41. PubMed ID: 25367150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate versus rhythm control in atrial fibrillation.
    Frankel G; Kamrul R; Kosar L; Jensen B
    Can Fam Physician; 2013 Feb; 59(2):161-8. PubMed ID: 23418244
    [No Abstract]   [Full Text] [Related]  

  • 4. Rate control in atrial fibrillation: many questions still unanswered.
    Van Gelder IC; Hobbelt AH; Mulder BA; Rienstra M
    Circulation; 2015 Oct; 132(17):1597-9. PubMed ID: 26384161
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacological rate control therapy for atrial fibrillation].
    Ishikawa T
    Nihon Rinsho; 2013 Jan; 71(1):72-8. PubMed ID: 23631175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate-control treatment and mortality in atrial fibrillation.
    Chao TF; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
    Circulation; 2015 Oct; 132(17):1604-12. PubMed ID: 26384160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate control in atrial fibrillation.
    Dorian P
    N Engl J Med; 2010 Apr; 362(15):1439-41. PubMed ID: 20231233
    [No Abstract]   [Full Text] [Related]  

  • 8. [Drugs for heart rate control and non-antiarrhythmic drugs in atrial fibrillation].
    Chávez LL
    Arch Cardiol Mex; 2007; 77 Suppl 2():S2-54-S2-58. PubMed ID: 17972380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic control of heart rate in atrial fibrillation.
    Falk RH
    Cardiol Clin; 1996 Nov; 14(4):521-36. PubMed ID: 8950054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rate control at least as effective as rhythm control for AF patients.
    Geriatrics; 2002 May; 57(5):63. PubMed ID: 12040594
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacological control of rate and maintenance of sinus rhythm.
    Ezekowitz MD; Lampert R
    J Thromb Thrombolysis; 1999 Jan; 7(1):33-8. PubMed ID: 10337358
    [No Abstract]   [Full Text] [Related]  

  • 12. Circadian variation of variability and irregularity of heart rate in patients with permanent atrial fibrillation: relation to symptoms and rate control drugs.
    Corino VD; Platonov PG; Enger S; Tveit A; Ulimoen SR
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(12):H2152-7. PubMed ID: 26497961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate vs rhythm control in atrial fibrillation: can observational data trump randomized trial results?
    Dewland TA; Marcus GM
    Arch Intern Med; 2012 Jul; 172(13):983-4. PubMed ID: 22665022
    [No Abstract]   [Full Text] [Related]  

  • 14. Diltiazem versus metoprolol for the management of atrial fibrillation: A systematic review and meta-analysis.
    Jafri SH; Xu J; Warsi I; Cerecedo-Lopez CD
    Am J Emerg Med; 2021 Oct; 48():323-327. PubMed ID: 34274577
    [No Abstract]   [Full Text] [Related]  

  • 15. Atrial fibrillation: how to approach rate control.
    Rosenfeld LE
    Curr Cardiol Rep; 2005 Sep; 7(5):391-7. PubMed ID: 16105496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical practice. Newly diagnosed atrial fibrillation.
    Page RL
    N Engl J Med; 2004 Dec; 351(23):2408-16. PubMed ID: 15575057
    [No Abstract]   [Full Text] [Related]  

  • 17. Innovative Therapeutics for Atrial Fibrillation: Imminent Breakthroughs or Much Ado About Nothing?
    Nattel S; Dobrev D
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):409-11. PubMed ID: 26371951
    [No Abstract]   [Full Text] [Related]  

  • 18. Status of Antiarrhythmic Drug Development for Atrial Fibrillation: New Drugs and New Molecular Mechanisms.
    Hanley CM; Robinson VM; Kowey PR
    Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002479. PubMed ID: 26936819
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effects of anti-arrhythmia agents on heart rate. Significance and importance].
    Leclercq JF; Georgiopoulos G; Halkidis H; Attuel P; Maisonblanche P; Coumel P
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():37-46. PubMed ID: 6122434
    [No Abstract]   [Full Text] [Related]  

  • 20. Beta-blockade and A1-adenosine receptor agonist effects on atrial fibrillatory rate and atrioventricular conduction in patients with atrial fibrillation.
    Corino VD; Holmqvist F; Mainardi LT; Platonov PG
    Europace; 2014 Apr; 16(4):587-94. PubMed ID: 23989533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.